ERYTECH to Host on May 7, 2019 First Quarter Conference Call and Business Update

17:30 EDT 2 May 2019 | GlobalNewsWire (2014)
This article has expired, however you can still download the PDF.
Lyon (France), March 2, 2019 - ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today ann...

Other Sources for this Article


More From BioPortfolio on "ERYTECH to Host on May 7, 2019 First Quarter Conference Call and Business Update"

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...